Best Practices in Communicating with Healthcare Stakeholders
Effective communication of information plays a strategic role in developing relationship and trust. A clear set of rules and regulations support the quality of a system and guide healthcare communicators on how to shape their communication strategies. Healthcare stakeholders include a wide range of individuals and organizations, such as pharma industries, clinicians, advocacy groups, and policymakers.
Patients are increasingly well informed about their disease and potential treatment options. They use social media platforms to connect and discuss with other patients. An emerging group is interested in co-driving their own treatment schedule and want to become more involved in the R&D process.
Communicating with and among healthcare stakeholders, e.g. the preparation of a market launch or the information about scientific results is often shaped by risk management, which despite careful assessment can lead to unexpected crises situations, requiring professional crisis management. Last but not least the potential pitfalls, when sharing insider information, will be highlighted – an often overlooked area, where misconduct can result in harsh consequences.
This online seminar brings together a broad range of experts that come from a variety of professions who will share their insight on making decisions and communicating with and among a diverse group of healthcare stakeholders.
Join us on February 4, 2021 to reflect, learn from and discuss with the experts on this multifaceted topic.
About Frontiers in Drug Development Seminars
ECPM offers one day seminars on new trends and developments in drug development science. These seminars provide the opportunity to integrate work and further education, to discuss with experts face-to-face and to build an international network. They take place on the fourth day of each of the six modules of the Diploma Course and are mandatory for students taking the Diploma Course. Additionally, they are open to our alumni and other interested scientists and can be booked separately.
Participants should learn more about various topic such as:
- Future trends in drug development including Future Information Technologies, Nano-Technologies, Computer Simulation and Modeling, Personalized Medicine, Genomics, Biologicals and Biosimilars, Advanced Therapeutics.
- Regulatory Agency updates from FDA, EMA and Swissmedic.
- Ethical, Economic and Epidemiological Considerations and Concepts in Drug Development.
One-day workshops, recognised for continuing professional development. The workshops are held on day four of each ECPM Course Module. Please find the agenda in the brochure, offered for download further below (brochure will be available asap).
Six workshops over a period of two years, which equal 1 ECTS credit. Accredited as continuing education with eight credits by the Swiss Society of Pharmaceutical Medicine (SGPM) and the Swiss Society of Pharmaceutical Professionals (SwAPP). Accredited with 50 FPH-points in hospital pharmacy and 50 FPH-points in clinical pharmacy and the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).
Course fee including certificate and electronic course material is CHF 680 and CHF 580 for ECPM Alumni and SwAPP/SGPM members
A reduced fee applies to participants from academia and nonprofit organizations.
For Master of Medicines Development (MMD) participants, the fee of this module is not included in the MMD tuition fee.
Refund of fees, less 30% administrative charges will be given if cancellations are received in written format (firstname.lastname@example.org) by Monday, January 25, 2021. After this date no refund can be given for cancellations. Speakers are subject to change without notice.
Date and Venue
February 4, 2021
Online via Zoom
Deadline for Registration
January 18, 2021
This seminar is organized by the European Center of Pharmaceutical Medicine.
Subscribe to our ECPM Newsletter to stay informed about upcoming courses and seminars.